Stem cell culture conditions and stability: a joint workshop of the PluriMes Consortium and Pluripotent Stem Cell Platform
Authors listGlyn N Stacey Peter W Andrews Ivana Barbaric Charlotta Boiers Amit Chandra Giulio Cossu Lynn Csontos Thomas Jr Frith Jason A Halliwell Zoe Hewitt Mark McCall Harry D Moore Malin Parmar M Beatrice Panico Venkat Pisupati Valentin P Shichkin Alison R Stacey Francesco Saverio Tedesco Oliver Thompson Ravenska Wagey
Human stem cells have the potential to transform medicine. However, hurdles remain to ensure that manufacturing processes produce safe and effective products. A thorough understanding of the biological processes occurring during manufacture is fundamental to assuring these qualities and thus, their acceptability to regulators and clinicians. Leaders in both human pluripotent and somatic stem cells, were brought together with experts in clinical translation, biomanufacturing and regulation, to discuss key issues in assuring appropriate manufacturing conditions for delivery of effective and safe products from these cell types. This report summarizes the key issues discussed and records consensus reached by delegates and emphasizes the need for accurate language and nomenclature in the scientific discourse around stem cells.